Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R Crow

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Pediatric Hematology/Oncology|December 12, 2003
Role of Fcgamma receptors in the pathogenesis and treatment of idiopathic thrombocytopenic purpuraAndrew R Crow, Alan H Lazarus
Transfusion Medicine Reviews|March 21, 2008
The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?Andrew R Crow, Alan H Lazarus
Seminars in Hematology|June 18, 2016
Mechanistic properties of intravenous immunoglobulin in murine immune thrombocytopenia: support for FcγRIIB falls by the waysideAndrew R Crow, Alan H Lazarus
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 3, 2003
Mechanism of action of IVIG and anti-D in ITPAlan H Lazarus, Andrew R Crow
Transfusion|December 16, 2014
CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruptionAndrew R Crow, Alaa Amash, Alan H Lazarus
Transfusion Medicine Reviews|January 11, 2003
Understanding platelet function through signal transductionAlan H Lazarus, Seng Song, Andrew R Crow
Pediatric Blood & Cancer|August 26, 2006
Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopeniaAndrew R Crow, Seng Song, Vinayakumar Siragam, et al.
Plos One|August 14, 2013
Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathwayAndrew R Crow, Honghui Yu, Dongji Han, et al.
Blood|December 31, 2002
Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIGSeng Song, Andrew R Crow, John Freedman, et al.
Blood|October 14, 2004
Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIgSeng Song, Andrew R Crow, Vinayakumar Siragam, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Pediatric Hematology/Oncology|December 12, 2003
Role of Fcgamma receptors in the pathogenesis and treatment of idiopathic thrombocytopenic purpuraAndrew R Crow, Alan H Lazarus
Transfusion Medicine Reviews|March 21, 2008
The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?Andrew R Crow, Alan H Lazarus
Seminars in Hematology|June 18, 2016
Mechanistic properties of intravenous immunoglobulin in murine immune thrombocytopenia: support for FcγRIIB falls by the waysideAndrew R Crow, Alan H Lazarus
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 3, 2003
Mechanism of action of IVIG and anti-D in ITPAlan H Lazarus, Andrew R Crow
Transfusion|December 16, 2014
CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruptionAndrew R Crow, Alaa Amash, Alan H Lazarus
Transfusion Medicine Reviews|January 11, 2003
Understanding platelet function through signal transductionAlan H Lazarus, Seng Song, Andrew R Crow
Pediatric Blood & Cancer|August 26, 2006
Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopeniaAndrew R Crow, Seng Song, Vinayakumar Siragam, et al.
Plos One|August 14, 2013
Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathwayAndrew R Crow, Honghui Yu, Dongji Han, et al.
Blood|December 31, 2002
Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIGSeng Song, Andrew R Crow, John Freedman, et al.
Blood|October 14, 2004
Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIgSeng Song, Andrew R Crow, Vinayakumar Siragam, et al.
Pageof 3